If you sell first aid kits into the United Kingdom, one document shapes your product more than any other: BS 8599-1, the British Standard for workplace first aid kits. In April 2026 it was amended — published as BS 8599-1:2019+A1:2026 — and the amendment matters commercially, because it expands what the standard covers and recalibrates what "a properly equipped British first aid kit" means.
It is worth being precise about status from the start. BS 8599-1 is not law. UK first aid obligations come from the Health and Safety (First-Aid) Regulations 1981, which require employers to provide adequate first aid equipment based on a needs assessment — they do not mandate a specific standard. But in practice, BS 8599-1 is the benchmark the market and the courts use to judge what "adequate" means, and the Health and Safety Executive (HSE) treats it as the recognised reference when assessing whether provision is reasonable. In other words: not complying with a law, but ignoring the standard is how you lose the argument afterwards.
That combination — voluntary on paper, decisive in practice — makes the 2026 amendment something every UK-facing importer should understand in detail. Here is what changed, and what it means for the kits you source.
AEDs are now in scope. The amendment is the first edition of BS 8599-1 to address automated external defibrillators. Cardiac arrest survival collapses by roughly ten percent for every minute without defibrillation, and the standard now reflects the reality that AEDs have become normal workplace equipment rather than specialist kit. For kit designers and sellers, the practical consequences are placement guidance and packaging that accommodate AED-adjacent storage — a kit range that assumes an AED nearby is now the baseline assumption for medium and larger workplaces.
New kit categories enter the framework. The amendment formally recognises kit types that the market had already invented ad hoc: major injury kits, designed for high-hazard environments where serious trauma is foreseeable; burns kits, dedicated to thermal injury rather than generic wound care; and eye wash kits, aligned with the growing number of workplaces assessed as carrying eye-injury risk. It also formalises personal issue kits for lone and travelling workers — a direct response to how work has changed. A first aid room at headquarters helps nobody working alone on a remote site, and the standard now says so in product terms.
The travel and vehicle provisions were sharpened. BS 8599-2 covers motor vehicle kits, and the amendment clarifies how employers should assess company vehicles — a delivery van supporting remote sites has a very different risk profile from a car doing office-to-office runs. The in-kit "travel kit" category was also renamed and recalibrated.
Contents quantities were adjusted. Small, medium, large and travel kits saw item-level changes — quantities of dressings, wipes, gloves and foil blankets were recalibrated against usage data. Nothing dramatic, but enough that a kit configured to the 2019 text is no longer a precise match to the current one.
Two things did not change and are worth saying, because they trip up overseas suppliers constantly. First, the needs assessment still comes first: the amendment explicitly does not make existing kits obsolete, and employers are expected to review rather than automatically repurchase. Second, medicines remain out of scope — with the single exception of aspirin for a suspected heart attack, tablets do not belong in a BS 8599 kit, and a "kit with painkillers included" is a compliance liability, not a feature.
The BS 8599 amendment did not appear in a vacuum. In 2026, HSE updated its first-aid guidance to use the term "life-threatening bleeding" and to state clearly that where a needs assessment identifies such risk — manufacturing, engineering, construction, agriculture, forestry, machinery — employers should consider equipment beyond the conventional kit: haemostatic dressings, wound-packing gauze and commercially manufactured tourniquets.
We covered that guidance change in detail here. The connection matters for product planning, because the two documents move together: HSE defines the duty, BS 8599-1 defines the product. A workplace told by its regulator to plan for life-threatening bleeding will look for a major injury or catastrophic bleed kit built to a recognised specification — and that is exactly the category the amendment formalises.
The same convergence is happening across our other markets. Canada's CSA Z1220 made windlass tourniquets mandatory in Type 2 and 3 kits, and the US ANSI/ISEA Z308.1-2026 revision — published in September — tightened tourniquet specifications and flagged counterfeit devices. We covered the US change here. For a brand selling across English-speaking markets, bleeding control is moving from specialist accessory to expected kit content in all of them — but each market formalises it differently, and the UK route runs through BS 8599 and the needs assessment.
Three mistakes cost UK-focused importers money every year, and the amendment sharpens all three.
Mistake one: selling a "universal" kit. The British market is unusually specification-literate. Distributors' catalogues, procurement portals and tender documents reference BS 8599-1 sizes by name — small, medium, large, travel, personal issue. A generic "50-piece first aid kit" imported from a generic contents list does not map onto that vocabulary, and buyers who understand the standard will ask which BS size it matches. If the answer is "none", you are selling outside the mainstream channel.
Mistake two: ignoring the refill economy. Britain runs on refills. Because the standard defines contents by kit size, the natural commercial cycle is: buy the case once, then buy contents to the standard for years. Suppliers who sell only complete kits compete for the one-off purchase and lose the annuity. A BS 8599-aligned refill programme — contents packs matched to each kit size, with expiry dating — is how the British channel actually works.
Mistake three: confusing the standard with market access. Meeting BS 8599-1 does not replace the regulatory layer. Kits containing medical components sold in Great Britain still need the compliance route we described in our guide to UK market access — CE/UKCA status, the MHRA registration picture and the 2028/2030 transition deadlines all still apply. The standard tells you what a good kit contains; it does not tell you how to lawfully place it on the market. You need both answers, and they come from different documents.
At Kebon we manufacture first aid kits to specified contents lists, and the British standard is one of the specifications we build against. In practice, that means three things for UK-facing programmes.
Kit sizes that map to the standard's vocabulary. We configure small, medium, large, travel and personal-issue formats with contents matched to the BS 8599-1 tables, so a distributor can list the product against the size the buyer's needs assessment produced. The same production platform also covers the adjacent categories the amendment formalised — major injury and burns configurations — plus the tactical and trauma packs that serve the high-hazard end of the market.
Refills as a first-class product line. Because the UK channel runs on replenishment, we build contents packs matched to kit sizes as a deliberate programme, with batch and expiry management built in — not as an afterthought to kit sales.
Documentation that survives buyer scrutiny. Contents lists generated from the bill of materials, batch traceability, and the labelling capability the market expects. Where a configuration question affects compliance classification, we flag it at quotation — the same discipline we apply across markets. Our workplace medical first aid kits and industrial first aid kits are built on this documentation base.
Planning a UK range for 2027? Send us the kit sizes and workplace profiles your customers serve, and we will come back with configurations matched to the standard's sizes — plus the refill structure that makes the programme repeatable.
If you sell or plan to sell first aid kits in the UK, the amendment translates into a short, concrete list:
Map your current range against the standard's categories. Which of your SKUs match a BS 8599 size, and which are generic? Which of the new categories — major injury, burns, eye wash, personal issue — is your range missing? The gaps are the growth products for 2027.
Review bleeding-control positioning. With HSE guidance and the standard moving together, a major injury or bleed-control configuration is now a mainstream catalogue item, not a niche line. Check your contents lists against what the market will expect to find.
Build the refill programme before your competitors do. The distributor who owns the refill cycle owns the customer. If your factory can supply standard-matched contents packs with honest expiry dating, say so explicitly in your next trade conversation.
Keep the compliance layer current. Standards change faster than regulations, and regulations change faster than websites. The UK picture — CE/UKCA, MHRA reform, the transition deadlines — needs a check at least twice a year; we keep ours updated in the market-access guide linked above.
And ask your supplier the version question directly. "Which edition of BS 8599-1 is this kit configured to?" A supplier who answers with the 2026 amendment and its specific content changes has been paying attention. A supplier who asks which edition you mean has not — and that difference will show up somewhere in the product.
Do employers have to replace all existing kits because of the amendment?
No. The amendment does not make compliant, in-date kits obsolete. Employers are expected to review their provision through the needs assessment and upgrade where the assessment justifies it — which in practice means the change enters the market through replacement cycles and new specifications, not a cliff-edge buyout.
Is BS 8599-1 legally required in the UK?
No. The 1981 Regulations require adequate first aid provision based on a needs assessment, without mandating a standard. But HSE and the courts use BS 8599-1 as the practical benchmark for "adequate", so the standard functions as the market's reference specification.
Do BS 8599 kits include painkillers or other medicines?
No. With the sole exception of aspirin for a suspected heart attack, medicines are not part of the standard, and including tablets in a workplace kit creates compliance problems rather than value.
What is the difference between BS 8599-1 and BS 8599-2?
BS 8599-1 covers workplace first aid kits; BS 8599-2 covers motor vehicle kits. Employers with company vehicles should assess vehicle use separately, since a works van supporting remote sites carries a different risk profile from a city runabout.
Can one kit specification serve both the UK and other markets?
Increasingly the bleeding-control content converges, but the frameworks differ — the UK runs on BS 8599 sizes and the needs assessment, North America on ANSI and CSA configurations. A single global specification is achievable, but it should be a deliberate engineering decision with the documents in front of you, not an assumption.
Does Kebon manufacture to BS 8599-1 configurations?
Yes. We build to specified contents lists against the standard's size framework, with refill packs matched to each size. Send us your target sizes and market and we will quote the configuration with full documentation.